stars 1 stars 2 stars 3

Vector Vitale is developing a breakthrough class of therapeutic molecules that correct the structure of biomolecules, including amino acids, polypeptides, and proteins, and can be re-dosed to achieve a sustainable effect against degenerative diseases, with applications in medicine, defense, space, and related industries.

Vector Vitale Questions

The Vector Vitale annual revenue was $3 million in 2026.

Peter Novak is the Principal CEO of Vector Vitale.

1 people are employed at Vector Vitale.

Vector Vitale is based in Miami, Florida.

The NAICS codes for Vector Vitale are [33, 31, 32, 3122, 312, 325].

The SIC codes for Vector Vitale are [28, 21, 20, 283].

Top Vector Vitale Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users